 REHOVOT, Israel and WILMINGTON, Del., Jan. 06, 2022 GLOBE NEWSWIRE -- Ayala Pharmaceuticals, Inc. Nasdaq: AYLA, a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations, today announced that it will present at the H.C. Wainwright BioConnect Virtual Conference, taking place on January 10-13, 2022. 